• Subscribe

    Webinars & Whitepapers →

    ▾
  • Xconomy Boston

  • Xperience
    Tech + Life
      • Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
        Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
      • Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
        Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
      • Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
        Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
      • John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
        John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
      • As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
        As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
      View More in Xperience ›
  • EXOME
    Biotech + Health
      • 3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug
        3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug
      • Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
        Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
      • FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal
        FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal
      • Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More
        Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More
      • Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results
        Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results
      View More in EXOME ›
  • Our
    Regions
    • Boston ›
      • FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder
        FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder
      View More in Boston ›
    • Boulder/Denver ›
      • PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
        PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
        Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
        Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
      View More in Indiana ›
    • New York ›
      • 6 Experimental Alzheimer's Disease Diagnostics Projects Get Funding Boost
        6 Experimental Alzheimer's Disease Diagnostics Projects Get Funding Boost
      View More in New York ›
    • Raleigh-Durham ›
      • Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
        Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
      View More in Raleigh-Durham ›
    • San Diego ›
      • 3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug
        3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug
      View More in San Diego ›
    • San Francisco ›
      • Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck
        Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck
      View More in San Francisco ›
    • Seattle ›
      • A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
        A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
      View More in Seattle ›
    • Texas ›
      • Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
        Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
      View More in Texas ›
    • Wisconsin ›
      • AI Can Unlock Health Data's Potential, But Access Is Still Difficult
        AI Can Unlock Health Data's Potential, But Access Is Still Difficult
      View More in Wisconsin ›
  • Tech
    Channels
    • Agtech and Food›
      • Hi Fidelity Genetics Raises $8.5M to Improve Plant Breeding With AI
        Hi Fidelity Genetics Raises $8.5M to Improve Plant Breeding With AI
      View More in Agtech and Food ›
    • Cleantech›
        View More in Cleantech ›
      • Cybersecurity›
          View More in Cybersecurity ›
        • Education›
            View More in Education ›
          • EXOME: Biotech + Health›
            • Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
              Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
            View More in EXOME ›
          • Fintech›
              View More in Fintech ›
            • Healthtech›
              • AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
                AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
              View More in Healthtech ›
            • Robotics and A.I.›
              • Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
                Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
              View More in Robotics and A.I. ›
            • Startups›
              • Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio
                Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio
              View More in Startups ›
            • Xperience: Tech + Life›
                View More in Xperience ›
            • Meet the
              Xconomists
              • Bart Lorang

                Bart Lorang

                CEO, FullContact

              • Bill Clarke

                Bill Clarke

                Medical College of Wisconsin director of research commercialization

              • Bill McKeon

                Bill McKeon

                Vice president, chief strategy and operating officer of the Texas Medical Center

              • Alan Saltiel

                Alan Saltiel

                Director, Life Sciences Institute, University of Michigan

              • Meet All the Xconomists ›
              • Alan Frazier

                Alan Frazier

                Founder and Managing Partner, Frazier Healthcare Ventures

              • Elizabeth Hagerman

                Elizabeth Hagerman

                Vice President for Corporate Engagement, Rose-Hulman Institute of Technology

              • Alan McGlade

                Alan McGlade

                Founder and Managing Director of DEV

              • Gerry Hays

                Gerry Hays

                Serial Entrepreneur and Investor

            • Our
              Events
              • All Xconomy Events › Boston Events ›
              • Boulder/Denver Events › Detroit/Ann Arbor Events ›
              • Indiana Events › New York Events ›
              • Raleigh-Durham Events ›San Diego Events ›
              • San Francisco Events ›Seattle Events ›
              • Texas Events › Wisconsin Events ›
            • Xpertise
              Watch + Learn
            • Boston Home
            • Boston Events
            • Archives
            • Xconomists
            • X Lists
            • VC / M&A Deals

            From 5AM Ventures, an Early Stage Biotech VC Still Standing, Raises $250M:

            5am1
            5am1—

            5AM Ventures

            Underwriters and Partners

            Xpertise: Watch + Learn
            • How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

              Xconomy Insight · Special Report

              How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

              Insights, wisdom, and inspiration on what it takes

            • 2019 Biopharma Outlook – Facing an Uncertain Future

              From Our Editors · Special Report

              2019 Biopharma Outlook – Facing an Uncertain Future

              Key indicators & expert insight from industry leaders

              Xconomy
            • Robert Langer reveals secrets to early-stage biotech success

              From Our Partners · Special Report

              Robert Langer reveals secrets to early-stage biotech success

              Advice for funding and future transformational opportunities

            Connect with Xconomy

            • Xconomy on Facebook
            • Xconomy on Twitter
            • Xconomy on Linkedin
            • Xconomy on Google PLus
            • Xconomy Feeds

            Xconomy on Demand

            Did you miss something? Don't despair…

            Xconomy offers a number of ways to subscribe for free!

            Subscribe Now
            IDG Tech Network
            Protected by Carbonite
            Eventbrite - events made easy
            • Home
            • Privacy/DMCA
            • Security Disclosures
            • About
            • Contact Us
            • Archives
            • Advertise
            • Subscribe for Free

            Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

            © 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

            Website development support from Andrew Koyfman with design support from Rob Hunter.